Systematic review of influenza resistance to the neuraminidase inhibitors
about
The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviewsNeuraminidase inhibitors for preventing and treating influenza in children (published trials only)Neuraminidase inhibitors for preventing and treating influenza in childrenInfluenza treatment and prophylaxis with neuraminidase inhibitors: a reviewProlonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferretsRisk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivirThe Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug DesignViral Infection in the Development and Progression of Pediatric Acute Respiratory Distress SyndromeEstimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza virusesEvaluation of three influenza neuraminidase inhibition assays for use in a public health laboratory setting during the 2011-2012 influenza seasonIn vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.Antiviral activity of Ladania067, an extract from wild black currant leaves against influenza A virus in vitro and in vivoContinuing challenges in influenza.Why is coinfection with influenza virus and bacteria so difficult to control?Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza.Influenza: clinical symptoms, diagnostics and therapyIn vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.Rethinking approaches to improve the utilization of nucleic acid amplification tests for detection and characterization of influenza A in diagnostic and reference laboratories.Influenza virus resistance to neuraminidase inhibitors: implications for treatment.Peramivir for the treatment of influenza.Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemicRecent progress and challenges in the discovery of new neuraminidase inhibitors.Subtyping of influenza neuraminidase using mass spectrometry.Emerging antiviral strategies to interfere with influenza virus entry.Effects of green tea gargling on the prevention of influenza infection in high school students: a randomized controlled studyAntiviral drug resistance as an adaptive processActivation of A1-adenosine receptors promotes leukocyte recruitment to the lung and attenuates acute lung injury in mice infected with influenza A/WSN/33 (H1N1) virusPostinfection A77-1726 treatment improves cardiopulmonary function in H1N1 influenza-infected micePreclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit.3-O-galloylated procyanidins from Rumex acetosa L. inhibit the attachment of influenza A virus.Quantitative trace analysis of a broad range of antiviral drugs in poultry muscle using column-switch liquid chromatography coupled to tandem mass spectrometry.Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in KoreaTreatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents.Antiviral activity of phenanthrenes from the medicinal plant Bletilla striata against influenza A virusOseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza.A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase.Synthetic Mucus Nanobarriers for Identification of Glycan-Dependent Primary Influenza A Infection Inhibitors.Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections.A review of neuraminidase inhibitor susceptibility in influenza strains.Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain.
P2860
Q21090775-92D32446-ADB5-450F-8A05-A8B573277428Q24200222-13DA0869-54BA-475A-B1F9-DF639B4969FFQ24203875-5283C0BE-3603-4D93-97BC-CA1FC68D4CF0Q26860032-AAE21B63-3F2A-4C4A-8FF2-17EA4955003EQ27334946-C21165F2-317B-4CFC-80D6-3AEB15A6990BQ28066861-7D8E0AEF-A51A-4F90-9628-A4AC24199C8FQ28071809-0243BAF3-7E0D-4501-9887-2F5717359E79Q28071857-463658A6-DE42-4BB8-8228-95539A90B990Q28541953-C147E508-E552-48B8-8D53-7A6A40E8F4BDQ30353294-F19B8003-9935-4B27-A7BA-0ECC64973B04Q30356466-C1FF07F4-6142-431D-AF4A-3CBA14EABF30Q30362204-4E88582D-5AB4-4499-A0AA-733BF62824B1Q30363190-6C75613D-C47B-46D9-B0A2-AA973F04CFF9Q30371269-4ABCFA03-2DA7-4989-BFDF-001EC1AE3C4BQ30398606-2EF0B046-001E-4187-BAFC-1BE46B9FA189Q30405546-8363D150-4167-46F8-A6AB-7E59FBED9485Q30407184-CAA0236B-72AE-4B66-AD64-D6658ADA1B5FQ30410029-F5262A32-CCDC-4966-9F9C-A6E4641209C3Q30411822-FED2F605-A9B4-4F41-A7D7-E967EAA1F743Q30413154-EE76D718-015E-456D-8BF5-6942B34C9E5EQ30415228-B07D58AF-244D-4E4B-9832-75110F59D808Q30426630-C90F5D3E-F82F-4105-A203-D05F8C5248DEQ30426648-E8DD79DB-7306-4067-B11C-65C7EEF58D04Q30432421-DA479EDE-AFE3-421F-B5D5-B12F31DB27D6Q33623705-6D1E1865-4CCD-4ACF-B38D-FB9D791CA97EQ33878407-B4E9220D-BF55-4066-ACC2-024406B1264CQ34059472-6F86A1A0-3170-42D9-AF5E-B0325BC2BCB4Q34296984-6831815C-5444-4093-BB10-55E0F89D80F5Q35076802-5D966CAB-C08C-4D3C-A032-CE9CE1DB9A4BQ35321520-63DA6831-2CF7-4D08-AE3F-8DA37D1F1F4FQ35685732-58840F68-8EDA-4039-BEA8-5E40C8090704Q36296560-B9341FD3-7C66-4961-9A5C-AC87E777FA8DQ36301052-B6401377-0736-46A4-877F-C8DA713A09F8Q36377969-F64FD5A3-AFEA-40EE-90B6-9FC4010A988AQ36584645-541928C8-EDC4-4A4F-81E5-091C877AF3A4Q36666497-F961786A-367C-4119-A00F-89F39BA56699Q37374096-F9F25D4F-667D-4BA4-B4C2-47AA3E7C4A7BQ37913363-DD94B6F1-6311-4B9C-B0BA-0B03696B9534Q38258646-BB8A2DC7-94EB-49D4-9C53-A0E7559DB37AQ38299435-F81BA103-D04E-41BA-BC25-15F76F8EB473
P2860
Systematic review of influenza resistance to the neuraminidase inhibitors
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Systematic review of influenza resistance to the neuraminidase inhibitors
@ast
Systematic review of influenza resistance to the neuraminidase inhibitors
@en
Systematic review of influenza resistance to the neuraminidase inhibitors
@en-gb
Systematic review of influenza resistance to the neuraminidase inhibitors
@nl
type
label
Systematic review of influenza resistance to the neuraminidase inhibitors
@ast
Systematic review of influenza resistance to the neuraminidase inhibitors
@en
Systematic review of influenza resistance to the neuraminidase inhibitors
@en-gb
Systematic review of influenza resistance to the neuraminidase inhibitors
@nl
prefLabel
Systematic review of influenza resistance to the neuraminidase inhibitors
@ast
Systematic review of influenza resistance to the neuraminidase inhibitors
@en
Systematic review of influenza resistance to the neuraminidase inhibitors
@en-gb
Systematic review of influenza resistance to the neuraminidase inhibitors
@nl
P2860
P31
P50
P921
P3181
P356
P1476
Systematic review of influenza resistance to the neuraminidase inhibitors
@en
P2093
Guy Boivin
P2860
P2888
P3181
P356
10.1186/1471-2334-11-134
P407
P5008
P577
2011-05-19T00:00:00Z
P5875
P6179
1050018382